These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16267879)

  • 1. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.
    Neogi T; Hunter DJ; Chaisson CE; Allensworth-Davies D; Zhang Y
    J Rheumatol; 2006 Jan; 33(1):104-9. PubMed ID: 16267879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
    Hunter DJ; York M; Chaisson CE; Woods R; Niu J; Zhang Y
    J Rheumatol; 2006 Jul; 33(7):1341-5. PubMed ID: 16758506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system.
    Mikuls TR; Curtis JR; Allison JJ; Hicks RW; Saag KG
    J Rheumatol; 2006 Mar; 33(3):562-6. PubMed ID: 16482645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The online case-crossover study is a novel approach to study triggers for recurrent disease flares.
    Zhang Y; Chaisson CE; McAlindon T; Woods R; Hunter DJ; Niu J; Neogi T; Felson DT
    J Clin Epidemiol; 2007 Jan; 60(1):50-5. PubMed ID: 17161754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
    Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M
    J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in the management of gout.
    Keith MP; Gilliland WR
    Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy and prescribing quality in older people.
    Steinman MA; Landefeld CS; Rosenthal GE; Berthenthal D; Sen S; Kaboli PJ
    J Am Geriatr Soc; 2006 Oct; 54(10):1516-23. PubMed ID: 17038068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.
    Elliot AJ; Cross KW; Fleming DM
    Ann Rheum Dis; 2009 Nov; 68(11):1728-33. PubMed ID: 19029167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study.
    So MW; Lee SG; Kim YG; Lee CK; Yoo B
    Scand J Rheumatol; 2011 Nov; 40(6):444-7. PubMed ID: 21916803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and risk factors of postsurgical gout.
    Kang EH; Lee EY; Lee YJ; Song YW; Lee EB
    Ann Rheum Dis; 2008 Sep; 67(9):1271-5. PubMed ID: 17998214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis.
    Ferraz MB; O'Brien B
    J Rheumatol; 1995 May; 22(5):908-14. PubMed ID: 8587081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate prescription of allopurinol in a teaching hospital.
    Athisakul S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 May; 90(5):889-94. PubMed ID: 17596042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal risk of gout attacks.
    Choi HK; Niu J; Neogi T; Chen CA; Chaisson C; Hunter D; Zhang Y
    Arthritis Rheumatol; 2015 Feb; 67(2):555-62. PubMed ID: 25504842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.